Berg, Parkinson’s Institute Announce Study Focused on Biomarker Discovery|
Thursday, February 20, 2014
Third phase of collaboration aims to unravel mysteries of disease by identifying disease markers and potential new drug targets.
Bruker Reports 7% Revenue Growth in Q4
Wednesday, February 19, 2014
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
The Role of Mass Spectrometry in the "Omics" Era
Tuesday, February 18, 2014
The tremendous developments of the MS technology and concurrent gene sequencing efforts have made the “-omic” revolution possible.
G3 Completes GLOBAL Study Patient Enrollment
Thursday, February 13, 2014
Pilot data of single largest prospective pan-omic study to identify key biomarkers and central therapeutic targets for cardiovascular diseases.
Metabolomics: Taking Aim at Diabetic Kidney Failure
Saturday, February 08, 2014
Krolewski and his Joslin colleagues search for better ways of predicting which diabetic people are at risk for ESRD.
Omega-3 Fatty Acids have Wider Range of Biological Impacts
Wednesday, February 05, 2014
Study explored the challenges the liver faces from the “Western diet” that increasingly is linked to liver inflammation, fibrosis, cirrhosis and sometimes liver failure.
Speeding Validation of Disease Targets
Tuesday, February 04, 2014
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
PerkinElmer Revenues Grow 4%
Monday, February 03, 2014
PerkinElmer, Inc. reported financial results for the fourth quarter ended December 29, 2013.
Thermo Reports 6% Q4 Revenue Growth
Friday, January 31, 2014
Thermo Fisher Scientific Inc. reported its financial results for the fourth quarter and full year ended December 31, 2013.